Skip to content
Subscriber Only

Johnson & Johnson Wins First Pinnacle Hip Implant Injury Trial

Updated on

A Johnson & Johnson unit’s design of a metal-on-metal version of its Pinnacle hip implants isn’t defective, a Dallas jury concluded, ruling against a woman who said the devices poisoned her in the first case of its kind to go to trial.

The ULTAMET artificial hips sold by J&J’s DePuy subsidiary as part of its Pinnacle line of implants had no design defects and the company properly warned patients and doctors about the devices’ risks, jurors in federal court in Dallas concluded yesterday.